JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma

Guardado en:

Detalles Bibliográficos
Autores principales:	Nobukazu Fujimoto, Yosuke Miyamoto, Sae Wada, Katsuyuki Hotta, Toshiyuki Kozuki, Keisuke Aoe, Jun Sakurai, Michihiro Yoshida, Daijiro Harada
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/af8197ea96ff4fda8b8b228a37b81135
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:af8197ea96ff4fda8b8b228a37b81135
record_format	dspace
spelling	oai:doaj.org-article:af8197ea96ff4fda8b8b228a37b811352021-12-04T01:00:05ZJME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma10.1136/jitc-2021-0032882051-1426https://doaj.org/article/af8197ea96ff4fda8b8b228a37b811352021-10-01T00:00:00Zhttps://jitc.bmj.com/content/9/10/e003288.fullhttps://doaj.org/toc/2051-1426Nobukazu FujimotoYosuke MiyamotoSae WadaKatsuyuki HottaToshiyuki KozukiKeisuke AoeJun SakuraiMichihiro YoshidaDaijiro HaradaBMJ Publishing GrouparticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Nobukazu Fujimoto Yosuke Miyamoto Sae Wada Katsuyuki Hotta Toshiyuki Kozuki Keisuke Aoe Jun Sakurai Michihiro Yoshida Daijiro Harada JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
format	article
author	Nobukazu Fujimoto Yosuke Miyamoto Sae Wada Katsuyuki Hotta Toshiyuki Kozuki Keisuke Aoe Jun Sakurai Michihiro Yoshida Daijiro Harada
author_facet	Nobukazu Fujimoto Yosuke Miyamoto Sae Wada Katsuyuki Hotta Toshiyuki Kozuki Keisuke Aoe Jun Sakurai Michihiro Yoshida Daijiro Harada
author_sort	Nobukazu Fujimoto
title	JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
title_short	JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
title_full	JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
title_fullStr	JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
title_full_unstemmed	JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
title_sort	jme-001 phase ii trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/af8197ea96ff4fda8b8b228a37b81135
work_keys_str_mv	AT nobukazufujimoto jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT yosukemiyamoto jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT saewada jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT katsuyukihotta jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT toshiyukikozuki jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT keisukeaoe jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT junsakurai jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT michihiroyoshida jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma AT daijiroharada jme001phaseiitrialoffirstlinecombinationchemotherapywithcisplatinpemetrexedandnivolumabforunresectablemalignantpleuralmesothelioma
_version_	1718373050013974528

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma

Ejemplares similares